# ARROWHEAD PHARMACEUTICALS, INC. (ARWR) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from ARROWHEAD PHARMACEUTICALS, INC.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/ARWR/mda/fy2025/): filed 2025-11-25; accession 0000879407-25-000029 (https://www.sec.gov/Archives/edgar/data/879407/000087940725000029/arwr-20250930.htm); latest 10-K
- [FY 2024 MD&A](/company/ARWR/mda/fy2024/): filed 2024-11-26; accession 0001628280-24-049277 (https://www.sec.gov/Archives/edgar/data/879407/000162828024049277/arwr-20240930.htm)
- [FY 2023 MD&A](/company/ARWR/mda/fy2023/): filed 2023-11-29; accession 0001628280-23-040219 (https://www.sec.gov/Archives/edgar/data/879407/000162828023040219/arwr-20230930.htm)
- [FY 2022 MD&A](/company/ARWR/mda/fy2022/): filed 2022-11-28; accession 0001628280-22-030869 (https://www.sec.gov/Archives/edgar/data/879407/000162828022030869/arwr-20220930.htm)
- [FY 2021 MD&A](/company/ARWR/mda/fy2021/): filed 2021-11-22; accession 0001564590-21-057888 (https://www.sec.gov/Archives/edgar/data/879407/000156459021057888/arwr-10k_20210930.htm)

Back to /company/ARWR/